FXYD6 overexpression in HBV-related hepatocellular carcinoma with
cirrhosis

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis

The aim of this study was to investigate the expression of FXYD domain-containing ion transport regulator 6 (FXYD6) mRNA and protein in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) tissues with cirrhosis, the corresponding parac...

Full description

Bibliographic Details
Main Authors:	Chen Xiongfei, Ding Lishuang, Kong Deshuai, Zhao Xiulei, Liao Lili, Zhang Yaomin, Li Fengshan, Liu Ruhai
Format:	Article
Language:	English
Published:	De Gruyter 2020-04-01
Series:	Open Life Sciences
Subjects:	fxyd6 hepatocellular carcinoma hepatitis b virus microvascular invasion early recurrence
Online Access:	https://doi.org/10.1515/biol-2020-0027

Similar Items

Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation
by: Weiliang Hou, et al.
Published: (2023-12-01)

FXYD5: Na+/ K+-ATPase Regulator in Health and Disease.
by: Irina eLubarski Gotliv
Published: (2016-03-01)

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide
by: Kaijia Zhou, et al.
Published: (2021-11-01)

<i>FXYD3</i> Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
by: Satoru Yonekura, et al.
Published: (2022-07-01)

Effect of hepatitis B virus DNA replication level and anti-HBV therapy on microvascular invasion of hepatocellular carcinoma
by: Chao Qu, et al.
Published: (2019-01-01)

High-Intensity Training Represses FXYD5 and Glycosylates Na,K-ATPase in Type II Muscle Fibres, Which Are Linked with Improved Muscle K<sup>+</sup> Handling and Performance
by: Morten Hostrup, et al.
Published: (2023-03-01)

FXYD8, a Novel Regulator of Renal Na+/K+-ATPase in the Euryhaline Teleost, Tetraodon nigroviridis
by: Pei-Jen Wang, et al.
Published: (2017-08-01)

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury
by: Patricia L. Brazee, et al.
Published: (2017-06-01)

Identification of zebrafish FXYD11a protein that is highly expressed in ion-transporting epithelium of the gill and skin and its possible role in ion homeostasis
by: Kaori Saito, et al.
Published: (2010-08-01)

Insulin-Like Growth Factor-1 Down-Regulates the Phosphorylation of FXYD1 and Rescues Behavioral Deficits in a Mouse Model of Rett Syndrome
by: Zhe-Feng Yuan, et al.
Published: (2020-01-01)

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways
by: María José Besso, et al.
Published: (2019-12-01)

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways
by: María José Besso, et al.
Published: (2024-01-01)

The guiding value of microvascular invasion for treating early recurrent small hepatocellular carcinoma
by: Xuqi Sun, et al.
Published: (2021-01-01)

Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma
by: Qingquan Bai, et al.
Published: (2023-12-01)

Microvascular invasion risk scores affect the estimation of early recurrence after resection in patients with hepatocellular carcinoma: a retrospective study
by: Sheng Wang, et al.
Published: (2022-11-01)

Treatment of patients with HBV cirrhosis: Successes, unsolved problems
by: I G Bakulin, et al.
Published: (2013-12-01)

Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma
by: Xiang-Pan Meng, et al.
Published: (2023-09-01)

Effect of Microvascular Invasion on the Prognosis in Hepatocellular Carcinoma and Analysis of Related Risk Factors: A Two-Center Study
by: Wang Yanhan, et al.
Published: (2021-11-01)

A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study
by: Wang H, et al.
Published: (2024-01-01)

Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
by: Joon Yeul Nam, et al.
Published: (2020-12-01)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
by: Jiang Y, et al.
Published: (2021-05-01)

Early and late recurrence after hepatectomy in patients with low-level HBV-DNA hepatocellular carcinoma under antiviral therapy
by: Ziqiang Li, et al.
Published: (2022-11-01)

Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection
by: Shilei Bai, et al.
Published: (2023-04-01)

Hepatitis C-Related Cirrhosis with Sustained Prevention of Hepatocellular Carcinoma Recurrence by Long-Term Administration of Super-Low-Dose Peginterferon-Alpha 2b
by: Satoshi Mamori, et al.
Published: (2011-01-01)

Effect of Ouabain on Glutamate Transport in the Hippocampus of Rats with LPS-Induced Neuroinflammation
by: Israel José Pereira Garcia, et al.
Published: (2023-03-01)

Association Study Between Polymorphic Loci in Cholesterol Metabolism Pathway and Gallstone in the Tibetan Population
by: Lifeng Ma, et al.
Published: (2022-05-01)

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study
by: Hang-Dong Jia, et al.
Published: (2021-07-01)

Impact of Surgical Margin on the Prognosis of Early Hepatocellular Carcinoma (≤5 cm): A Propensity Score Matching Analysis
by: Han Wang, et al.
Published: (2020-05-01)

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
by: Meng-Chao Wei, et al.
Published: (2022-06-01)

Study of liver in HBV-related hepatocellular carcinoma: Stereology shows quantitative differences in liver structure
by: Bita Moudi, et al.
Published: (2018-09-01)

Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma
by: Si-Si Huang, et al.
Published: (2023-01-01)

Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma
by: Xiulan Xue, et al.
Published: (2020-02-01)

Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
by: Bin Sun, et al.
Published: (2023-11-01)

MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity
by: Chen Z, et al.
Published: (2023-09-01)

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
by: Kai-Qian Zhou, et al.
Published: (2020-12-01)

HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China
by: Yueming Chen, et al.
Published: (2012-11-01)

Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2–3 cm: Comparison of Resection and Ablation
by: Shuanggang Chen, et al.
Published: (2021-10-01)

Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma
by: Ziming He, et al.
Published: (2023-07-01)

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion
by: Hongxing Zhang, et al.
Published: (2020-02-01)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
by: Pierre Nahon, et al.
Published: (2021-01-01)